Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,950 | 2 | 87.5% |
| Unspecified | $542.30 | 2 | 9.6% |
| Food and Beverage | $164.97 | 3 | 2.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $5,492 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $133.60 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $31.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.61 | 1 | Novartis Pharmaceuticals Corporation ($58.61) |
| 2023 | $74.99 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($74.99) |
| 2019 | $224.40 | 1 | GENZYME CORPORATION ($224.40) |
| 2018 | $317.90 | 1 | GENZYME CORPORATION ($317.90) |
| 2017 | $4,981 | 3 | GENZYME CORPORATION ($4,950) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $58.61 | General |
| Category: Immunology | ||||||
| 11/03/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $74.99 | General |
| 03/05/2019 | GENZYME CORPORATION | LEMTRADA (Drug) | — | In-kind items and services | $224.40 | Research |
| Study: A long-term follow up study for multiple sclerosis patients who have completed the alemtuzumab extension study • Category: MULTIPLE SCLEROSIS | ||||||
| 11/28/2018 | GENZYME CORPORATION | LEMTRADA (Drug) | — | In-kind items and services | $317.90 | Research |
| Study: A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) • Category: MULTIPLE SCLEROSIS | ||||||
| 04/05/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 04/04/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/05/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab extension study (CAMMS03409) | GENZYME CORPORATION | $317.90 | 1 |
| A long-term follow up study for multiple sclerosis patients who have completed the alemtuzumab extension study | GENZYME CORPORATION | $224.40 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 121 | 323 | $50,984 | $8,388 |
| 2022 | 5 | 61 | 160 | $30,914 | $5,250 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 25 | 174 | $22,620 | $4,393 | 19.4% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 23 | 24 | $13,694 | $1,543 | 11.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 24 | 26 | $4,680 | $843.44 | 18.0% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 25 | 27 | $5,670 | $842.13 | 14.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 24 | 72 | $4,320 | $766.80 | 17.8% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Office | 2022 | 13 | 90 | $13,300 | $3,002 | 22.6% |
| 88348 | Electron microscopy for diagnosis | Office | 2022 | 12 | 12 | $9,364 | $736.07 | 7.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 11 | 33 | $2,730 | $560.05 | 20.5% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Office | 2022 | 13 | 13 | $3,040 | $525.16 | 17.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 12 | 12 | $2,480 | $426.93 | 17.2% |
About Dr. Glen Markowitz, M.D
Dr. Glen Markowitz, M.D is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1457488736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glen Markowitz, M.D has received a total of $5,657 in payments from pharmaceutical and medical device companies, with $58.61 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($4,950).
As a Medicare-enrolled provider, Markowitz has provided services to 182 Medicare beneficiaries, totaling 483 services with total Medicare billing of $13,638. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 02/27/2007
- Last Updated 07/08/2007
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1457488736
Products in Payments
- LEMTRADA (Drug) $3,017
- NO PRODUCT DISCUSSED (Drug) $2,475
- Fabhalta (Drug) $58.61
- SOLIRIS (Drug) $31.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Dr. Maureen Zakowski, Md, MD
Anatomic Pathology — Payments: $45,149
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029